|
GSTCD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.63969999999303E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.189300E-04 |
| Normal-vs-Stage2 |
5.83229999999713E-05 |
| Normal-vs-Stage3 |
5.556400E-04 |
| Normal-vs-Stage4 |
6.423500E-03 |
| Stage1-vs-Stage2 |
1.571410E-01 |
| Stage1-vs-Stage3 |
6.641400E-01 |
| Stage1-vs-Stage4 |
7.031200E-01 |
| Stage2-vs-Stage3 |
2.809800E-01 |
| Stage2-vs-Stage4 |
3.943400E-01 |
| Stage3-vs-Stage4 |
9.547400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.983200E-03 |
| Normal-vs-AfricanAmerican |
7.019300E-04 |
| Normal-vs-Asian |
1.61707999999372E-05 |
| Caucasian-vs-AfricanAmerican |
9.766500E-02 |
| Caucasian-vs-Asian |
1.211970E-02 |
| AfricanAmerican-vs-Asian |
8.051600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.605700E-04 |
| Normal-vs-Female |
7.79010000000468E-05 |
| Male-vs-Female |
9.283000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.262300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.158600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.91690000000056E-05 |
| Normal-vs-Age(81-100Yrs) |
7.030000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.995200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.297600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.674800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.430600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.834800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.370800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.568200E-01 |
| Classical-VS-Follicular |
2.23689999856447E-08 |
| Classical-VS-Other |
3.761000E-01 |
| Classical-VS-Normal |
7.263700E-03 |
| Tall-VS-Follicular |
1.835790E-03 |
| Tall-VS-Other |
3.130600E-01 |
| Tall-VS-Normal |
2.069400E-01 |
| Follicular-VS-Other |
4.187000E-01 |
| Follicular-VS-Normal |
1.73050018759113E-10 |
| Other-VS-Normal |
3.582400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.37960000004644E-06 |
| Normal-vs-N1 |
4.218500E-03 |
| N0-vs-N1 |
3.943400E-01 |
|
|
